atezolizumab

Synlogic Collaborates with Roche to Evaluate the Combination of SYNB1891 and Tecentriq (atezolizumab) for Advanced Solid Tumors

Shots:                                                                                                                                                Roche & Synlogic enter into a clinical collaboration to evaluate the combination therapy of Synlogic’s SYNB1891 with Roche’s Tecentriq (atezolizumab) to treat [Read More...]